Legato Capital Management LLC Haemonetics Corp Transaction History

Legato Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$81.24 - $97.37 $49,881 - $59,785	614 Added 8.22%	8,088 $669,000
Q1 2024 Apr 15, 2024	BUY	$71.24 - $85.35 $268,289 - $321,428	3,766 Added 101.56%	7,474 $637,000
Q4 2023 Jan 16, 2024	SELL	$80.59 - $92.61 $433,654 - $498,334	-5,381 Reduced 59.2%	3,708 $317,000
Q3 2023 Oct 12, 2023	BUY	$82.56 - $93.49 $326,689 - $369,939	3,957 Added 77.1%	9,089 $814,000
Q2 2023 Aug 17, 2023	BUY	$80.84 - $89.45 $183,102 - $202,604	2,265 Added 79.0%	5,132 $436,000
Q1 2023 May 25, 2023	SELL	$72.75 - $90.6 $21,970 - $27,361	-302 Reduced 9.53%	2,867 $237,000
Q4 2022 Feb 01, 2023	BUY	$73.85 - $86.14 $234,030 - $272,977	3,169 New	3,169 $249,000
Q1 2018 Apr 19, 2018	SELL	$60.72 - $74.41 $802,961 - $983,997	-13,224 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$40.38 - $44.87 $533,985 - $593,360	13,224	13,224 $593,000

348

55.7M

600K

474K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.35B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Legato Capital Management LLC with notifications on news.